| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.2M | -51.8% |
| R&D Expense | $94.4M | -13.5% |
| SG&A Expense | $26.8M | -16.3% |
| Operating Income | -$96.0M | -8.0% |
| Pre-tax Income | -$87.9M | -5.2% |
| Income Tax | -$58K | +98.9% |
| Net Income | -$87.9M | -12.6% |
| EPS (Basic) | -$2.36 | +0.0% |
| EPS (Diluted) | -$2.36 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.7M | +52.3% |
| Accounts Receivable | $305K | -72.3% |
| Current Assets | $165.5M | -35.8% |
| Total Assets | $221.1M | -31.9% |
| Current Liabilities | $22.9M | -38.5% |
| Total Liabilities | $62.5M | -30.3% |
| Stockholders' Equity | $158.6M | -32.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.9M | +18.5% |
| Capital Expenditures | $574K | -81.6% |
| Investing Cash Flow | $103.5M | +217.4% |
| Financing Cash Flow | -$356K | -100.4% |
| Free Cash Flow | -$89.5M | +20.3% |
| +0.0% |